COMPANY PROFILE · /anima-biotech
A
Anima Biotech
AI drug discovery platform using its proprietary mRNA Lightning.AI platform to image hundreds of cellular pathways in healthy and diseased cells, training disease-specific AI models to identify dysregulated pathways and uncover novel drug targets. Combines functional genomics with deep learning for target validation.
Fresh · 5d ago
Latest valuation
—
Annual Recurring Revenue
—
Headcount
—
Funding total
$50M+
OVERVIEW
Has 20+ preclinical candidates in immunology, oncology, and neuroscience; Lightning.AI platform uses neural networks to distinguish diseased from healthy cells; represents distinct approach using high-content phenotypic profiling for target discovery.
Status
active
Tier
master-list
Profitability
—
Pricing
enterprise
FUNDING HISTORY · 0
No funding rounds on file.
PRODUCTS · 0
No products catalogued yet. Press Refresh above to ask the research agent.
TEAM · 0 key people
No people linked.
SOURCES · 0 cited
No citations stored yet. Run the research agent to attach per-claim sources.